Skip to main content
. 2019 Jan 8;39(1):BSR20180906. doi: 10.1042/BSR20180906

Figure 3. Knockdown of FEZF1-AS1 suppresses NPC tumorigenesis in vivo.

Figure 3

(A) Tumor volume growth curves were plotted. (B) The average tumor weight in each group was shown. (C) RT-qPCR analysis of FEZF1-AS1 expression in the xenograft tissues. (D) The expression levels of p21 and Cyclin D1 in the xenograft tissues were detected by Western blot analysis. Data are presented as the mean ± SD (n = 5/group). *P<0.05 versus sh-NC group.